Genesystem Co., Ltd. (KOSDAQ:363250)
South Korea · Delayed Price · Currency is KRW 4,170.00
-20.00 (-0.48%)
At close: Oct 2, 2026
Genesystem Market Cap
Genesystem has a market cap or net worth of 34.55 billion as of October 2, 2026. Its market cap has decreased by -16.81% in one year.
Market Cap
34.55B
Enterprise Value
33.46B
Revenue
1.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,170.00
ChartMarket Cap Chart
Since May 26, 2021, Genesystem's market cap has decreased from 118.51B to 34.55B, a decrease of -70.84%. That is a compound annual growth rate of -20.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 34.55B | 23.56% |
| Dec 30, 2025 | 27.96B | -52.89% |
| Dec 30, 2024 | 59.36B | -8.92% |
| Dec 28, 2023 | 65.17B | 12.35% |
| Dec 29, 2022 | 58.00B | -26.36% |
| Dec 30, 2021 | 78.77B | -33.54% |
| May 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SELVAS Healthcare | 68.41B |
| DRGEM | 56.44B |
| Dynamic solution | 55.90B |
| QuantaMatrix | 46.41B |
| JPI Healthcare | 45.28B |
| Genoray | 42.40B |
| UXN Co., Ltd. | 30.71B |
| CU Medical Systems | 27.78B |